SUBMISSION PROCESS AND REQUIREMENTS OF NORDIC HEALTH TECHNOLOGY ASSESSMENT (HTA) AUTHORITIES FOR HOSPITAL DRUGS: IMPLICATIONS FOR MARKET ACCESS STRATEGY

被引:0
|
作者
Aronsson, M. [1 ]
Ling, C. [2 ]
Stevenson, A. [2 ]
Brodtkorb, T. H. [3 ]
机构
[1] RTI HS Nord, Manchester, Lancs, England
[2] RTI Hlth Solut, Manchester, Lancs, England
[3] RTI HS Nord, Ljungskile, Sweden
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PNS220
引用
收藏
页码:S798 / S798
页数:1
相关论文
共 6 条
  • [1] SUBMISSION PROCESS AND REQUIREMENTS OF NORDIC HEALTH TECHNOLOGY ASSESSMENT ORGANISATIONS FOR MEDICAL TECHNOLOGIES: RESULTS OF AN ONLINE SURVEY
    Kinderas, M.
    Gildea, L.
    Mordin, M.
    Long, J.
    D'Souza, V
    Ling, C.
    Warttig, S.
    Hartley, L.
    VALUE IN HEALTH, 2023, 26 (12) : S435 - S435
  • [2] THE INCREASING USE OF POPULATION-ADJUSTED INDIRECT COMPARISONS IN THE NICE HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSION PROCESS AND THE RESPONSE TO THESE METHODS
    Pooley, N.
    Kisomi, M.
    Embleton, N.
    Langham, S.
    VALUE IN HEALTH, 2022, 25 (12) : S49 - S49
  • [3] BENCHMARKING HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES FOR SETTING STANDARDS ON PHARMACOECONOMIC, PRICING, EVIDENCE, AND GENERAL SUBMISSION REQUIREMENTS: DEVELOPMENT OF A MULTIDIMENSIONAL RATING SCALE
    Mazumder, D.
    Kapoor, A.
    Gwatkin, N.
    Medeiros, C.
    VALUE IN HEALTH, 2015, 18 (07) : A854 - A854
  • [4] THE INCREASING USE AND ACCEPTANCE OF ALTERNATIVE STATISTICAL APPROACHES TO INDIRECT COMPARISON IN THE NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE (NICE) HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSION PROCESS
    Pooley, N.
    Marjenberg, Z.
    Embleton, N.
    Langham, S.
    VALUE IN HEALTH, 2019, 22 : S814 - S814
  • [5] UK HEALTH TECHNOLOGY ASSESSMENT OF ORPHAN DRUGS FOR RARE ONCOLOGY VERSUS RARE DISEASE: DOES ORPHAN DESIGNATION MAKE ANY DIFFERENCE IN HTA PROCESS?
    Kelly, S.
    VALUE IN HEALTH, 2018, 21 : S467 - S467
  • [6] Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)-Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems
    Scuteri, Damiana
    Pierobon, Daniele
    Pagliaro, Martina
    Hamamura, Kengo
    Hayashi, Takafumi
    Pignolo, Loris
    Nicotera, Pierluigi
    Bagetta, Giacinto
    Corasaniti, Maria Tiziana
    PHARMACEUTICS, 2024, 16 (10)